Braun Stacey Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-44,672	Closed	-$21.7M	–	126
2025 Q1	$21.7M	Sell	44,672 -778	-2%	-$363K	0.89%	51
2024 Q4	$18.3M	Sell	45,450 -6,047	-12%	-$2.8M	0.68%	61
2024 Q3	$24M	Sell	51,497 -5,361	-9%	-$2.58M	0.91%	42
2024 Q2	$26.7M	Sell	56,858 -2,664	-4%	-$1.16M	1.03%	31
2024 Q1	$24.9M	Sell	59,522 -803	-1%	-$339K	0.98%	38
2023 Q4	$24.5M	Sell	60,325 -557	-0.9%	-$206K	1.1%	28
2023 Q3	$21.2M	Sell	60,882 -173	-0.3%	-$60.5K	1.03%	37
2023 Q2	$21.5M	Sell	61,055 -35,615	-37%	-$12M	1%	36
2023 Q1	$30.5M	Buy	+96,670	New	+$29M	0.8%	61
2020 Q4	–	Sell	-65,312	Closed	-$17.8M	–	139
2020 Q3	$17.8M	Sell	65,312 -670	-1%	-$185K	0.95%	36
2020 Q2	$19.2M	Buy	65,982 +7,099	+12%	+$1.92M	1.1%	19
2020 Q1	$14M	Buy	+58,883	New	+$13.5M	1.07%	34